Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 14, 2020 12:53PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Even though my shares seem to be tradeable as ZHCLF, I'm not convinced the are the same. Who would sell this low given buyout rumors are really picking up again.